Attached files
| file | filename |
|---|---|
| EX-99.1 - EXHIBIT 99.1 - HeartWare International, Inc. | c23781exv99w1.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934
Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): October 27, 2011
HEARTWARE INTERNATIONAL, INC.
(Exact name of registrant as specified in its charter)
| Delaware | 001-34256 | 26-3636023 | ||
| (State or other jurisdiction of incorporation) |
(Commission File Number) | (IRS Employer Identification No.) |
| 205 Newbury Street, Suite 101 Framingham, MA |
01701 |
|
| (Address of principal executive offices) | (Zip Code) |
Registrant’s telephone number, including area code: 508.739.0950
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| o | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | |
| o | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | |
| o | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | |
| o | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Item 5.02 Departure of Director or Certain Officers; Election of Directors; Appointment of Certain
Officers; Compensatory Arrangements of Certain Officers
On October 27, 2011, HeartWare International, Inc. (Nasdaq: HTWR — ASX: HIN) issued a press
release announcing that David McIntyre, Chief Financial Officer and Chief Operating Officer, plans
to relocate with his family back to Australia for personal reasons and will be leaving the Company.
Mr. McIntyre will continue with his responsibilities through the remainder of this year and will
be available throughout 2012 to assist with Australian operations and investor relations as needed.
A copy of the release is filed with this report as Exhibit 99.1.
Item 9.01 Financial Statements and Exhibits
(d) Exhibits
| Exhibit No. | Description | |||
| 99.1 | Press Release issued by HeartWare International, Inc. dated October 27, 2011. |
|||
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused
this report to be signed on its behalf by the undersigned hereunto duly authorized.
| HeartWare International, Inc. |
||||
| Date: October 27, 2011 | By: | /s/ Lawrence J. Knopf | ||
| Name: | Lawrence J. Knopf | |||
| Title: | Senior Vice President and General Counsel | |||
INDEX TO EXHIBITS
| Exhibit No. | Description | |||
| 99.1 | Press Release issued by HeartWare International, Inc. dated October 27, 2011. |
|||